[1]苏敬阳,曹 斌,张耀杰,等.外周血 Periostin表达水平与股骨头坏死塌陷进程的相关性研究[J].现代检验医学杂志,2022,37(01):190-194.[doi:10.3969/j.issn.1671-7414.2022.01.039]
 SU Jing-yang,CAO Bin,ZHANG Yao-jie,et al.Study on the Correlation between the Expression Level of Periostin in Peripheral Blood and the Collapse Process of FemoralHead Necrosis[J].Journal of Modern Laboratory Medicine,2022,37(01):190-194.[doi:10.3969/j.issn.1671-7414.2022.01.039]
点击复制

外周血 Periostin表达水平与股骨头坏死塌陷进程的相关性研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年01期
页码:
190-194
栏目:
检验与临床
出版日期:
2022-01-15

文章信息/Info

Title:
Study on the Correlation between the Expression Level of Periostin in Peripheral Blood and the Collapse Process of FemoralHead Necrosis
文章编号:
1671-7414(2022)01-190-05
作者:
苏敬阳曹 斌张耀杰郝学伟王 寅于海泉
(石家庄市人民医院骨科三病区, 石家庄050000)
Author(s):
SU Jing-yang CAO Bin ZHANG Yao-jie HAO Xue-wei WANG Yin YU Hai-quan
(Department of Orthopedics, Shijiazhuang People’s Hospital, Shijiazhuang 050000,China)
关键词:
Periostin股骨头坏死塌陷
分类号:
R681.8;R392.11
DOI:
10.3969/j.issn.1671-7414.2022.01.039
文献标志码:
A
摘要:
目的 研究外周血 Periostin表达与股骨头坏死塌陷进程的关系。方法 选取 2016年 8月 ~2019年 5月石家庄市人民医院收治的 110例股骨头坏死患者作为研究组。另纳入同期进行体检的 110例非股骨头坏死受试者作为对照组。测定受试者外周血中 Periostin水平。比较研究组和对照组 Periostin水平的差异;比较研究组患者不同病因及不同分期的 Periostin水平差异;比较研究组股骨头坏死塌陷前后的 Periostin水平差异;分析研究组患者外周血中 Periostin水平与病因及分期的相关性;采用 ROC曲线分析外周血中 Periostin在股骨头坏死塌陷的诊断效能。结果 研究组受试者外周血中 Periostin水平( 0.65±0.10)显著高于对照组( 0.65±0.10),差异有统计学意义( t=11.167,P<0.05)。研究组患者中国际骨循环研究会( ARCO)不同分期组间比较差异具有统计学意义( F=15.567,P<0.05),且Ⅲ期和Ⅳ期患者外周血中 Periostin水平( 0.82±0.14,0.87±0.15)显著高于Ⅱ期患者( 0.69±0.12),组间比较差异均具有统计学意义(均 P<0.05)。病因为酒精性、激素性、特发性及创伤性患者外周血中 Periostin水平比较差异无统计学意义( F=0.563, P>0.05)。研究组患者股骨头坏死塌陷后( 0.92±0.23)与塌陷前( 0.67±0.11)相比外周血中 Periostin水平显著升高,差异有统计学意义( t=6.465,P<0.05)。研究组 Periostin水平与 ARCO分期呈正相关( r=0.563,P<0.05)。股骨头坏死塌陷患者外周血中 Periostin的 AUC及 95%CI分别为 0.841(95%CI,0.786~0.895,P<0.001),提示外周血中 Periostin对股骨头坏死塌陷诊断效能较高。结论 外周血中 Periostin表达与股骨头坏死塌陷有密切关系,股骨头坏死塌陷后外周血中 Periostin水平显著升高,对股骨头坏死塌陷具有一定的诊断价值。
Abstract:
Objective To study the relationship between the expression of Periostin in peripheral blood and the collapse processof femoral head necrosis. Methods Selected 110 patients with femoral head necrosis admitted to Shijiazhuang People’s Hospitalfrom August 2016 to May 2019 as the research group. In addition, 110 subjects with non-femoral head necrosis admitted to thehospital for physical examination at the same time were included as the control group. The Periostin protein level in the peripheralblood of the subjects was determined. Compared the difference of Periostin levels between the study group and the control group.Compared the differences in the levels of Periostin in the study group with different causes and different stages, and compared thedifference of Periodin levels before and after the collapse of femoral head necrosis in the study group. Analyzed the correlationbetween the level of Periostin in the peripheral blood of the study group and the etiology and stage, and analyzed the diagnosticefficacy of Periostin in peripheral blood for femoral head necrosis collapse. Results The level of Periostin in the peripheralblood of the subjects in the study group(0.65±0.10) was significantly higher than that in the control group(0.65±0.10), thedifference was statistically significant (t=11.167,P<0.05). The difference between the ARCO stages of the study group wasstatistically significant (P<0.05), and the level of Periostin in the peripheral blood of patients with stage III and IV(0.82±0.14,0.87±0.15) was significantly higher than that of patients with stage II(0.69±0.12), and the differences between the groups werestatistically significant (P<0.05). The cause of the cause was that there was no statistically significant difference in the levels ofPeriostin in the peripheral blood of alcoholic, hormonal, idiopathic and trauma patients (P>0.05). After the femoral head necrosisof the study group collapsed, the level of Periostin in the peripheral blood(0.92±0.23) was significantly higher than that beforethe collapse(0.67±0.11),the difference was statistically significant (t=6.465,P<0.05). The level of Periodin in the study groupwas positively correlated with ARCO staging (r=0.563, P<0.05). The AUC and 95% CI of Periostin in peripheral blood ofpatients with femoral head necrosis collapse were 0.841 (95% CI, 0.786~0.895, P<0.001), and it suggesting that Periostin inperipheral blood had a higher diagnostic efficiency for femoral head necrosis collapse. Conclusion The expression of Periostinin peripheral blood was closely related to the collapse of femoral head necrosis. After the collapse of femoral head necrosis, thelevel of Periostin in peripheral blood increases significantly, which has certain diagnostic value for femoral head necrosiscollapse.

参考文献/References:

[1] 代志鹏, 王东辉, 焦竞博, 等. 微小RNA-219a-5p 通过靶向卷曲蛋白4 抑制激素性股骨头坏死中骨髓间充质干细胞的增殖和成骨分化[J]. 中华实验外科杂志, 2021, 38(2):305-308.DAI Zhipeng WANG Donghui, JIAO Jingbo, etal. MicroRNA-219a-5p inhibits proliferation andosteogenic differentiation of bone marrow mesenchymalstem cells in steroid-induced osteonecrosis of femoralhead by targeting Frizzled-4[J].Chinese Journal ofExperimental Surgery, 2021, 38(2):305-308.
[2] 陈长军, 赵鑫, 罗月, 等. 股骨头坏死保头治疗现状及预后影响因素的研究进展[J]. 中华骨科杂志,2021, 41(1):49-57.CHEN Changjun, ZHAO Xin, LUO Yue, et al.Research progress on current status of head-preservingtreatment for osteonecrosis of the femoral head and itsprognostic factors[J]. Chinese Journal of Orthopaedics,2021, 41(1):49-57.
[3] 王义生, 李劲峰. 股骨头坏死发病机制的研究现状与展望[J]. 中华实验外科杂志, 2020, 37(6):1001-1010.WANG Yisheng, LI Jinfeng. Research status andprospect of the pathogenesis of osteonecrosis of thefemoral head [J]. Chinese Journal of ExperimentalSurgery, 2020, 37(6):1001-1010.
[4] 刘一飞, 李盛华, 周明旺, 等. 基于“络病理论”探讨股骨头坏死的病因机制[J]. 时珍国医国药,2019,30(8): 1939-1941.LIU Yifei, LI Shenghua, ZHOU Mingwang, et al.Exploration of the etiology and mechanism of femoralhead necrosis based on“collateral disease theory”[J]. Lishizhen Medicine and Materia Medica Research,2019,30(8): 1939-1941.
[5] LI Doudou, ZHOU Weiwei, CAO Meng. Periostinmodifiedbone marrow mesenchymal stem cells fromosteoporotic rats promote alveolar bone regeneration[J].Journal of Molecular Histology, 2019, 50(6): 493-502.
[6] 中华医学会骨科分会显微修复学组. 中国修复重建外科专业委员会骨缺损及骨坏死学组. 成人股骨头坏死诊疗标准专家共识(2012 年版)[J]. 中华骨科杂志, 2012, 32(6 ): 606-610.Chinese Medical Association Orthopaedic Branchof Microscopic Repair Group,Bone Defect andOsteonecrosis Group, Chinese Committee of Repair andReconstructive Surgery. Expert consensus on diagnosisand treatment standards of adult femoral head necrosis(2012 edition)[J]. Chinese Journal of Orthopaedics,2012, 32(6 ): 606-610.
[7] 于冬冬, 杨关林, 侯德才. 骨头缺血性坏死的病因及分期辨证论治[J]. 辽宁中医杂志,2019,46(11):2338-2340.YU Dongdong, YANG Guanlin, HOU Decai. Etiologyand staged syndrome differentiation and treatmentof avascular necrosis of femoral head [J]. LiaoningJournal of Traditional Chinese Medicine, 2019, 46(11):2338-2340.
[8] 陈森, 聂志刚, 邓爽, 等. 骨软骨前体细胞在激素性股骨头坏死发生机制中的研究[J]. 中华实验外科杂志, 2020, 37(8):1501.CHEN Sen, NIE Zhigang, DENG Shuang, et al.Significance of Gremlin1+ stem cells in steroid-inducedosteonecrosis of the femoral head: a preliminary study[J]. Chinese Journal of Experimental Surgery, 2020,37(8):1501.
[9] 朱超, 姜彦峰. 股骨头坏死患者血清miRNA-210,miRNA-23b 检测的应用价值[J]. 现代检验医学杂志,2017, 32(4): 57-59,151.ZHU Chao,JIANG Yanfeng. Application value ofdetecting serum microRNA-210, miRNA-23b in thepatients with the femoral head necrosis [J]. Journal ofModern Laboratory Medicine,2017, 32(4): 57-59,151.
[10] 姜钰, 黄鑫, 朱颖波, 等. 成人股骨转子间骨折术后股骨头坏死研究进展[J]. 中国修复重建外科杂志,2020, 34(11):1458-1461.JIANG Yu, HUANG Xin, ZHU Yingbo, et al. Researchprogress in osteonecrosis of femoral head followingfemoral intertrochanteric fractures in adults [J]. ChineseJournal of Reparative and Reconstructive Surgery,2020, 34(11): 1458-1461.
[11] 何伟, 刘予豪, 周驰, 等. 非手术保髋治疗非创伤性股骨头坏死的临床研究[J]. 中国中西医结合杂志,2020, 40(2): 176-181.HE Wei, LIU Yuhao, ZHOU Chi, et al. Non-surgicaltherapeutic outcomes of nontraumatic osteonecrosisof femoral head [J]. Chinese Journal of IntegratedTraditional and Western Medicine, 2020, 40(2): 176-181.
[12] SONONGBUA J, SIRITUNGYONG S, THONGCHOTS, et al. Periostin induces epithelial-to-mesenchymaltransition via the integrin α5β1/TWIST-2 axis incholangiocarcinoma[J]. Oncology Reports, 2020, 43(4):1147-1158.
[13] ATTUR M, DUAN Xin, CAI Lei, et al. Periostin lossof-function protects mice from post-traumatic and agerelatedosteoarthritis[J]. Arthritis Research & Therapy,2021, 23(1): 104.
[14] KIM I S, SONG Wenqun, ARAKAWA H. Therole of Low-Level sodium fluoride in periodontalinflammation[J]. Journal of Hard Tissue Biology, 2019,28(2): 159-164.
[15] SCHMIDT J R, VOGEL S, MOELLER S, et al.Sulfated hyaluronic acid and dexamethasone possess asynergistic potential in the differentiation of osteoblastsfrom human bone marrow stromal cells[J]. Journal ofCellular Biochemistry, 2018, 120(5): 8706-8722.
[16] FARROKHI M, ARJAKI D, PEYKANPOUR F.Circulating Periostin levels increase in association withbone density loss and healing progression during theearly phase of hip fracture in Chinese older women[J].Osteoporosis International, 2020, 31(10): 2061.
[17] GAO Bo, DENG Ruoxian, CHAI Yu , e t a l .Macrophage-lineage TRAP+ cells recruit periosteumderivedcells for periosteal osteogenesis andregeneration[J]. The Journal of Clinical Investigation,2019, 129(6): 2578-2594.
[18] 丁瑞霞, 王慧明.Periostin 在牙周膜作用的研究进展[J]. 口腔医学研究, 2019, 35(7):635-638.DING Ruixia, WANG Huiming. Research of Periostinin the function of periodontal ligament [J]. Journal ofOral Science Research, 2019, 35(7):635-638.
[19] 尹孝亮, 陈世远, 郎德海, 等. 细胞基质蛋白Periostin 对血管内皮祖细胞迁移的影响[J]. 中华实验外科杂志, 2019,36(4):782.YIN Xiaoliang, CHEN Shiyuan, LANG Dehai, et al.The effect of Periostin on the migration of vascularendothelial progenitor cells [J]. Chinese Journal ofExperimental Surgery, 2019,36(4):782.
[20] 赵雪, 郝军, 戎赞华, 等. 敲低periostin 对PDGF 引起的系膜细胞增殖和细胞外基质表达的影响[J]. 中国药理学通报, 2019, 35(11): 1608-1612.ZHAO Xue, HAO Jun, RONG Zanhua, et al. Roleof Periostin in PDGF-induced proliferation andextracellular matrix accumulation of mouse mesangialcells [J]. Chinese Pharmacological Bulletin, 2019,35(11): 1608-1612.
[21] 卢永超, 王伟, 吕翱, 等. 炎症微环境下骨髓间充质干细胞骨向分化中Periostin 基因表达研究[J]. 口腔医学研究, 2020, 36(12): 1148-1152.LU Yongchao, WANG Wei, LU Ao, et al. Expressionof Periostin gene in osteogenic differentiation of bonemarrow mesenchymal stem cells in inflammatorymicroenvironment [J]. Journal of Oral ScienceResearch, 2020, 36(12): 1148-1152.

备注/Memo

备注/Memo:
基金项目:河北省卫生健康委员会医学科学研究课题计划项目(编号:20170970)。
作者简介:苏敬阳(1971-),男,硕士,副主任医师,研究方向:股骨头坏死。
更新日期/Last Update: 1900-01-01